Texas A&M University

Stories

FDA clears personalized magnetic brain therapy for PTSD after trial reports high remission

Ran the MeRT clinical trial and publicized results

The FDA cleared Wave Neuroscience's personalized magnetic brain therapy for PTSD on June 3, 2026. The clinical summary filed with the decision, K260402, reports that 68.2% of treated patients were in remission two to four months after treatment.

Updated Oct 27

Scientists find a cellular target for coffee's link to healthy aging

New Capabilities

As of July 2026: Institution behind the study

For decades, studies have linked coffee drinkers to lower rates of several age-related diseases. Nobody could say why. A Texas A&M lab now names a plausible reason: coffee compounds latch onto a cell receptor called NR4A1.

Updated Jul 19